86 related articles for article (PubMed ID: 20942676)
1. The origin of ovarian cancer—is it getting clearer?
Birrer MJ
N Engl J Med; 2010 Oct; 363(16):1574-5. PubMed ID: 20942676
[No Abstract] [Full Text] [Related]
2. [An "ariditary" form of ovarian cancer].
Birnbaum DJ; Sabatier R; Mamessier É; Birnbaum D; Bertucci F
Med Sci (Paris); 2010 Dec; 26(12):1040-2. PubMed ID: 21187041
[No Abstract] [Full Text] [Related]
3. Endometriosis-associated ovarian carcinomas.
Nissenblatt M
N Engl J Med; 2011 Feb; 364(5):482-3; author reply 484-5. PubMed ID: 21288105
[No Abstract] [Full Text] [Related]
4. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.
Yamashita Y
Jpn J Clin Oncol; 2015 May; 45(5):405-7. PubMed ID: 25583423
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
[TBL] [Abstract][Full Text] [Related]
9. Targeted epigenetic therapies: the next frontier?
Tuma RS
J Natl Cancer Inst; 2010 Dec; 102(24):1824-5. PubMed ID: 21139098
[No Abstract] [Full Text] [Related]
10. Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis.
Komiyama S; Aoki D; Katsuki Y; Nozawa S
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):130-6. PubMed ID: 16442693
[TBL] [Abstract][Full Text] [Related]
11. Endometriosis-associated ovarian carcinomas.
Birnbaum DJ; Birnbaum D; Bertucci F
N Engl J Med; 2011 Feb; 364(5):483-4; author reply 484-5. PubMed ID: 21288104
[No Abstract] [Full Text] [Related]
12. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma.
Otsuka J; Okuda T; Sekizawa A; Amemiya S; Saito H; Okai T; Kushima M; Tachikawa T
Med Electron Microsc; 2004 Sep; 37(3):188-92. PubMed ID: 15449112
[TBL] [Abstract][Full Text] [Related]
13. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.
Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Yamada H; Yamamoto R; Sakuragi N; Enokida H; Verma M; Dahiya R
Cancer; 2005 Nov; 104(9):1924-30. PubMed ID: 16134181
[TBL] [Abstract][Full Text] [Related]
14. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
Schwartz DR; Kardia SL; Shedden KA; Kuick R; Michailidis G; Taylor JM; Misek DE; Wu R; Zhai Y; Darrah DM; Reed H; Ellenson LH; Giordano TJ; Fearon ER; Hanash SM; Cho KR
Cancer Res; 2002 Aug; 62(16):4722-9. PubMed ID: 12183431
[TBL] [Abstract][Full Text] [Related]
15. Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer.
Ota K; Ito K; Akahira J; Sato N; Onogawa T; Moriya T; Unno M; Abe T; Niikura H; Takano T; Yaegashi N
Int J Gynecol Pathol; 2007 Jul; 26(3):334-40. PubMed ID: 17581421
[TBL] [Abstract][Full Text] [Related]
16. Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer.
Rebouissou S; Rosty C; Lecuru F; Boisselier S; Bui H; Le Frere-Belfa MA; Sastre X; Laurent-Puig P; Zucman-Rossi J
Oncogene; 2004 Sep; 23(45):7588-92. PubMed ID: 15326484
[TBL] [Abstract][Full Text] [Related]
17. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX
Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis and the neoplastic process.
Varma R; Rollason T; Gupta JK; Maher ER
Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis and ovarian cancer: a review.
Vlahos NF; Kalampokas T; Fotiou S
Gynecol Endocrinol; 2010 Mar; 26(3):213-9. PubMed ID: 19718562
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
